Literature DB >> 31866417

Immune-neuroendocrine and metabolic disorders in human and experimental T. cruzi infection: New clues for understanding Chagas disease pathology.

Florencia B González1, Silvina R Villar1, M Florencia Pacini1, Oscar A Bottasso1, Ana R Pérez2.   

Abstract

Studies in mice undergoing acute Trypanosoma cruzi infection and patients with Chagas disease, led to identify several immune-neuroendocrine disturbances and metabolic disorders. Here, we review relevant findings concerning such abnormalities and discuss their possible influence on disease physiopathology.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Adipose tissue; Chagas disease; Glucocorticoids; Hypothalamus-pituitary-adrenal axis; IL-1 beta; PPAR-γ

Mesh：

Year:  2019        PMID： 31866417     DOI： 10.1016/j.bbadis.2019.165642

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Basis Dis        ISSN： 0925-4439            Impact factor:   5.187


  3 in total

Review 1.  Shared neuroimmune and oxidative pathways underpinning Chagas disease and major depressive disorder.

Authors:  Eduardo Duarte-Silva; Michael Maes; Danielle Macedo; Wilson Savino; Christina Alves Peixoto
Journal:  Transl Psychiatry       Date:  2020-12-02       Impact factor: 6.222

Review 2.  Chagas heart disease: An overview of diagnosis, manifestations, treatment, and care.

Authors:  Roberto M Saraiva; Mauro Felippe F Mediano; Fernanda Sns Mendes; Gilberto Marcelo Sperandio da Silva; Henrique H Veloso; Luiz Henrique C Sangenis; Paula Simplício da Silva; Flavia Mazzoli-Rocha; Andréa S Sousa; Marcelo T Holanda; Alejandro M Hasslocher-Moreno
Journal:  World J Cardiol       Date:  2021-12-26

Review 3.  Longitudinal Speckle Tracking Strain Abnormalities in Chagas Disease: A Systematic Review and Meta-Analysis.

Authors:  Sergio Alejandro Gómez-Ochoa; Lyda Z Rojas; Juliana Alexandra Hernández-Vargas; Jorge Largo; Taulant Muka; Luis E Echeverría
Journal:  J Clin Med       Date:  2022-01-31       Impact factor: 4.241
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.